Screening for cardiovascular disease with cholesterol

被引:18
|
作者
Sullivan, DR [1 ]
机构
[1] Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia
关键词
cholesterol; screening; cardiovascular disease; prevention;
D O I
10.1016/S0009-8981(01)00720-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Total cholesterol (TC) and lipoprotein measurements are among the major risk factors for cardiovascular disease (CVD). Issues: The massive (and increasing) disease burden associated with cardiovascular disorders justifies public health measures, such as screening, which may assist with the identification and treatment of individuals who have a high risk of developing these disorders. Whole populations are placed at risk by environmental factors such as dietary habits and exercise patterns, and this may be reflected by simple tests such as TC that largely depend on dietary consumption of saturated fat and cholesterol. On the other hand, identification of high-risk individuals within populations requires more specific tests such as measurement of cholesterol in lipoprotein fractions. This recognizes that the contribution of different risk factors may vary between individuals. Dietary and pharmacological interventions, particularly those that reduce low-density lipoprotein cholesterol (LDL-C), have been shown to prevent the onset or recurrence of CVD. Conclusions: It is desirable and justifiable to try to identify high-risk patients before the onset of clinical CVD because morbidity and mortality may occur as a consequence of the initial event. The relationship between the costs and the benefits of prophylactic interventions varies according to the extent to which clinical procedures, including laboratory testing, can estimate the level of cardiovascular risk. It can be argued that inappropriate cholesterol screening may have a negative effect on health economics and patient attitudes, but these problems appear easily surmountable. Techniques that enable the preclinical detection of CVD may help the process to strike a balance between public health initiatives that reduce the environmental factors responsible for the epidemic of CVD, and the strategies that are known to reduce event rates in high-risk individuals. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [41] Screening for Cardiovascular Disease in CKD: COMMENTARY
    McCallum, Wendy
    Sarnak, Mark J.
    [J]. KIDNEY360, 2022, 3 (11): : 1839 - 1841
  • [42] Screening and management of pretransplant cardiovascular disease
    Wang, Jeffrey H.
    Kasiske, Bertram L.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (06): : 586 - 591
  • [43] STRESS TESTING IN SCREENING FOR CARDIOVASCULAR DISEASE
    BRUCE, RA
    MCDONOUGH, JR
    [J]. BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1969, 45 (12) : 1288 - +
  • [44] Screening for Cardiovascular Disease Risk with Electrocardiography
    Tracer, Howard
    Jadotte, Yuri T.
    [J]. AMERICAN FAMILY PHYSICIAN, 2018, 98 (06) : 375 - 376
  • [45] APPLICATION OF AI FOR SCREENING CARDIOVASCULAR DISEASE
    Kagiyama, Nobuyuki
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E104 - E104
  • [46] Screening for Cardiovascular Disease in CKD: PRO
    Jain, Nishank
    McAdams, Meredith
    Hedayati, S. Susan
    [J]. KIDNEY360, 2022, 3 (11): : 1831 - 1835
  • [47] The advisability of implementing cholesterol screening in school-age children and adolescents with a family history of cardiovascular disease and hyperlipidaemia
    Liu, CS
    Lin, CC
    Shih, HC
    Li, TC
    [J]. FAMILY PRACTICE, 1999, 16 (05) : 501 - 505
  • [48] Does dietary cholesterol promote diabetes and cardiovascular disease?
    Lichert, Frank
    [J]. AKTUELLE ERNAHRUNGSMEDIZIN, 2024, 49 (05): : 361 - 362
  • [49] Early exposure to cholesterol and risk of cardiovascular disease in adulthood
    Martin, Jean-Charles
    Aidoud, Nacima
    [J]. OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2015, 22 (02)
  • [50] Testosterone, HDL-cholesterol, and cardiovascular disease in men
    BarrettConnor, E
    [J]. PHARMACOLOGY, BIOLOGY, AND CLINICAL APPLICATIONS OF ANDROGENS: CURRENT STATUS AND FUTURE PROSPECTS, 1996, : 215 - 223